Total Costs & Expenses

$2.87B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Total Costs & Expenses

Latest reported$2.87Bperiod endingJun 30, 2026

REGN Quarterly Total Costs & Expenses ($0.00 → $2.87B)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

REGN total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	2,870,200,000
Mar 31, 2026	2,962,500,000
Dec 31, 2025	3,004,400,000
Sep 30, 2025	2,727,500,000
Jun 30, 2025	2,596,100,000
Mar 31, 2025	2,437,000,000
Dec 31, 2024	2,799,000,000
Sep 30, 2024	2,541,200,000
Jun 30, 2024	2,477,500,000
Mar 31, 2024	2,393,600,000
Dec 31, 2023	2,383,600,000
Sep 30, 2023	2,151,700,000
Jun 30, 2023	2,141,600,000
Mar 31, 2023	2,159,300,000
Dec 31, 2022	2,099,000,000
Sep 30, 2022	1,712,500,000
Jun 30, 2022	1,550,300,000
Mar 31, 2022	1,678,500,000
Dec 31, 2021	2,312,000,000
Sep 30, 2021	1,605,600,000
Jun 30, 2021	1,791,300,000
Mar 31, 2021	1,416,000,000
Dec 31, 2020	1,255,900,000
Sep 30, 2020	1,240,900,000
Jun 30, 2020	1,295,600,000
Mar 31, 2020	1,128,100,000
Dec 31, 2019	1,187,800,000
Sep 30, 2019	1,005,200,000
Jun 30, 2019	1,262,200,000
Mar 31, 2019	892,600,000
Dec 31, 2018	1,209,700,000
Sep 30, 2018	1,036,573,000
Jun 30, 2018	985,834,000
Mar 31, 2018	944,254,000
Dec 31, 2017	1,043,636,000
Sep 30, 2017	940,747,000
Jun 30, 2017	919,804,000
Mar 31, 2017	888,449,000
Dec 31, 2016	879,824,000
Sep 30, 2016	857,320,000
Jun 30, 2016	921,001,000
Mar 31, 2016	871,541,000
Dec 31, 2015	866,995,000
Sep 30, 2015	745,000,000
Jun 30, 2015	653,758,000
Mar 31, 2015	586,059,000
Dec 31, 2014	554,962,000
Sep 30, 2014	543,069,000
Jun 30, 2014	443,294,000
Mar 31, 2014	439,801,000
Dec 31, 2013	398,339,000
Sep 30, 2013	360,225,000
Jun 30, 2013	299,539,000
Mar 31, 2013	286,614,000
Dec 31, 2012	268,932,000
Sep 30, 2012	225,323,000
Jun 30, 2012	216,921,000
Mar 31, 2012	209,588,000
Dec 31, 2011	168,379,000
Sep 30, 2011	161,290,000
Jun 30, 2011	168,129,000
Mar 31, 2011	153,185,000
Dec 31, 2010	146,452,000
Sep 30, 2010	138,073,000
Jun 30, 2010	139,610,000
Mar 31, 2010	132,193,000
Dec 31, 2009	136,208,000
Sep 30, 2009	118,746,000
Jun 30, 2009	106,298,000
Mar 31, 2009	94,212,000
Dec 31, 2008	90,436,000
Sep 30, 2008	85,515,000
Jun 30, 2008	80,042,000
Mar 31, 2008	72,294,000
Dec 31, 2007	76,264,000
Sep 30, 2007	60,978,000
Jun 30, 2007	52,799,000
Mar 31, 2007	49,437,000
Dec 31, 2006	43,832,000
Sep 30, 2006	43,881,000
Jun 30, 2006	43,507,000
Mar 31, 2006	39,882,000
Dec 31, 2005	-201,891,000
Sep 30, 2005	50,581,000
Jun 30, 2005	48,533,000
Mar 31, 2005	44,549,000
Dec 31, 2004	43,116,000
Sep 30, 2004	45,998,000
Jun 30, 2004	41,061,000
Mar 31, 2004	38,196,000
Dec 31, 2003	38,411,000
Sep 30, 2003	43,095,000
Jun 30, 2003	37,464,000
Mar 31, 2003	38,515,000
Dec 31, 2002	39,546,000
Sep 30, 2002	38,742,000
Jun 30, 2002	35,519,000
Mar 31, 2002	30,134,000
Dec 31, 2001	33,994,000
Sep 30, 2001	28,774,000